EMBC Embecta Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: EMBC

Price (delayed)

$3.29

Market cap

$195.19M

P/E Ratio

1.71

Dividend/share

$0.46

EPS

$1.92

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 99
Relative Profitability: Rel. Profitability: 68
Highlights
The price to earnings (P/E) is 85% less than the 5-year quarterly average of 11.6 and 72% less than the last 4 quarters average of 6.2
The debt fell by 12% YoY and by 2.6% QoQ
EMBC's EPS has surged by 113% year-on-year but it is down by 20% since the previous quarter
EMBC's net income has surged by 112% year-on-year but it is down by 20% since the previous quarter
The quick ratio has declined by 11% since the previous quarter and by 10% year-on-year
EMBC's gross profit is down by 6% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Peers: OFIX

Key stats

What are the main financial stats of EMBC

EMBC stock price

How has the Embecta stock price performed over time
Intraday
1.23%
1 week
1.23%
1 month
6.13%
1 year
-71.09%
YTD
-72.31%
QTD
0.92%

Financial performance

How have Embecta's revenue and profit performed over time
Revenue
$1.04B
Gross profit
$645.1M
Operating income
$268.8M
Net income
$111.9M
Gross margin
61.9%
Net margin
10.7%
The net margin has soared by 118% YoY but it fell by 17% QoQ
EMBC's net income has surged by 112% year-on-year but it is down by 20% since the previous quarter
The operating margin has soared by 60% YoY but it has decreased by 6% from the previous quarter
The operating income has surged by 55% year-on-year but it has declined by 9% since the previous quarter

Price vs fundamentals

How does EMBC's price correlate with its fundamentals

Growth

What is Embecta's growth rate over time

Valuation

What is Embecta stock price valuation
EMBC P/E details
P/E
1.71
P/B
N/A
P/S
0.19
EV/EBIT
5.05
EV/EBITDA
4.25
EV/Sales
1.3
EMBC's EPS has surged by 113% year-on-year but it is down by 20% since the previous quarter
The price to earnings (P/E) is 85% less than the 5-year quarterly average of 11.6 and 72% less than the last 4 quarters average of 6.2
Embecta's equity has increased by 15% YoY but it has decreased by 2.1% QoQ
The stock's price to sales (P/S) is 79% less than its 5-year quarterly average of 0.9 and 68% less than its last 4 quarters average of 0.6
Embecta's revenue has decreased by 3.4% from the previous quarter and by 3.4% YoY

Efficiency

How efficient is Embecta business performance
The ROA has soared by 134% YoY but it has contracted by 18% from the previous quarter
The return on invested capital has surged by 76% year-on-year but it has declined by 7% since the previous quarter
EMBC's return on sales has surged by 68% year-on-year but it is down by 7% since the previous quarter

Dividends

What is EMBC's dividend history
Dividend details
DPS
$0.46
Dividend yield
13.98%
Payout ratio
24%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Embecta financials performed over time
The total assets is 38% less than the total liabilities
The total liabilities has decreased by 11% YoY
The quick ratio has declined by 11% since the previous quarter and by 10% year-on-year
Embecta's equity has increased by 15% YoY but it has decreased by 2.1% QoQ
The debt fell by 12% YoY and by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.